ПОЛИПЕПТИД ДЛЯ ИНГИБИРОВАНИЯ МИГРАЦИИ И ИНВАЗИИ ПЛОСКОКЛЕТОЧНОГО РАКА ПОЛОСТИ РТАТУГУЗБАЕВА, Г.М.,
В.Н. Павлов,
БАОФЕН, ЯН,
ЮНЛОНГ, БАЙ.,
G. M. TUGUZBAEVA,
Pavlov, V. N.,
BAOFENG, YANG,
YUNLONG, BAI (2019) применение полипептида, имеющего аминокислотную последовательность, соответствующую SEQ ID NO:
1, для
KHAZHIEV, S.Y.,
KHUSAINOV, M.A.,
KUZNETSOV, V.V.,
KHALIKOV, R.A.,
TYUMKINA, T.V.,
MESHCHERYAKOVA, E.S.,
KHALILOV, L.M. (2019) The structure of 5,5-bis(bromomethyl)-2-methyl-2-phenyl-
1,3-dioxane
1 has been studied by means
CHEN, Q.,
HAN, B.,
MENG, X.,
DUAN, C.,
YANG, C.,
WU, Z.,
MAGAFUROV, D.,
ZHAO, S.,
JIANG, C.,
CAI, J.,
SAFIN, S (2019) of microenvironmental genes. In vivo and in vitro experiments are used to verify the immunologic function of LGALS
1YANG, G.,
LIU, Z.,
CHEN, X.,
WANG, X.,
ZHANG, D.,
YANG, Z.,
SUN, J.,
XUE, L.,
GAO, M.,
LI, L.,
GAREEV, I.,
ZHAO, S.,
WANG, L.,
DONG, Q.,
ZHOU, Q.,
YI, R.,
AI, J. (2019) , neurological score, and levels of miR-195 and CX3CL
1/CX3CR
1 mRNA and protein expression were assessed in mice
TIMASHEVA, Y.R.,
NASIBULLIN, T.R.,
MUSTAFINA, O.E.,
BALKHIYAROVA, Z.R.,
PROKOPENKO, I.,
AVZALETDINOVA, D.S.,
MORUGOVA, T.V. (2019) related to type
1 diabetes mellitus (T
1D). However, most of these studies are performed in populations